Atrial Cardiac Organoid

  • Atrial Cardiac Organoid

Human iPSC-derived Atrial Cardiac Organoid

These organoids recapitulate atrial chamber-specific physiology in a 3D structure. They exhibit atrial-like action potentials, atrial-specific gene expression, and functional responses to compounds, enabling mechanistic studies, atrial arrhythmia modeling, and drug screening.

Benefits

  • Atrial-specific phenotype in 3D context
  • Suitable for atrial fibrillation and arrhythmia studies
  • High reproducibility and functional fidelity

Product Specifications

Feature

Detail

Identity Markers

High expression of atrial markers (MLC2a, NPPA, KCNA5), α-actinin alignment

Quantities

≥ 1 × 10⁶ cells per organoid

Quality Control

Electrophysiology (atrial APD), response to atrial-selective drugs, mycoplasma testing

Format

Cryopreserved organoids

Donor & Reprogramming

Healthy or disease-specific donor; Sendai virus reprogramming

Shipping / Storage

Dry shipper at -180°C to -135°C

Supplied with

Organoid medium and detailed instructions

Explore Atrial Cardiac Organoid

Discover our high-purity, iPSC-derived ventricular cardiomyocytes designed for cardiac safety, electrophysiology, and drug discovery research. Check out the product details to see how these cells can accelerate your studies.

Our Products